f i l t r a t i o n gave p a r a l l e l displacement curves. Results a r e expressed i n r e l a t i o n t o a standard pool of serum from normal adult males a r b i t r a r l y assigned a value c~f 1 U / m l SM.
1 1 adults and 7 children with C~s h i n g ' s syndrome were studied. In untreated patients, the mean f S. EM levels (0.85 f 0.07 U / m l , n=15)were not s i g n i f i c a n t l y d i f f e r e n t from those of normal adults (1.07tO.I,n=9). The c o r t i s o l levels were 20.9f2.7 pg/100ml (normal 10 5 0.5). In the 7 children wtose mean growth r a t e was 1.4 cmlyear, S M levels (0.86t0.12 L/ml) were s i g n i f i c a n t l y higher (p< 0.001) than those i n 8 hypopituitary dwarfs of the same age (0.2150.05). In 10 t r e a t e d p a t i e n t & , the mean S M levels were 1.0450. l l ~/ m l and the c o r t i s o l l e v e l s 4.7 t 1.6 pg/ml.
In 6 untreated p a t i e n t s , S M a c t i v i t y was determined by the chick embryo assay. Mean l e v e l s (0.72f0.06 U/ml) were below normal (pb0.05). The r e s u l t s would suggest that the growth a r r e s t i n Cushing's syndrome is not a consequence of impaired S M synthes i s . ; * g i f t s from Dr Zapf (~u r i c h )
T f g i f t from Dr Fryklund (AB Kabi, Stockholm). The effect of t h e sulfonylurea glitenclemide on different growth parameters i n hypophysectomized male r a t s .
Evidence has been presented t h a t i r s u l i n may be a growth promot i n g hormone. Therefore 26 male r a t s , bodyweight 60g, were hypophysectomized and injected i.p. for 10 days with s a l i n e ( A ) o r 1 mg/kg,lday glibenclamide (B). 24 hours a f t e r t h e l a s t i n j e c t i o n body weight,, serum insulin=IRI, serum somatomedin=SM (porcine c a r t i l a g e assay), and t h e epiphyseal p l a t e of t h e proximal t i b i a (Greenspan assay) were measured. After 10 days t h e weight gain was not d i f f e r e n t , while treatment had increased: IRI(A) 4.9 + M. DONNADIEU*, R.M. SCHIMPFF*, P. GARNIER, J L. CHAUSSAIN a n d J . C . JOB. H b p i t a l S a i n t -
:
V i n c e n t d e P a u l , P a r i s , F r a n c e . Somatomedin, g r o w t h hormone a n d g r o w t h v e l o c i t y : r e l a t i o n s h i p s w i t h t r a n s f e r r i n .
T r a n s f e r r i n ( T f ) , somatomed:in a c t i v i t y (SM), g r o w t h hormone (GH) a n d g r o w t h ve1oc:ity (GV) w e r e s t u d i e d i n 5 4 c h i l d r e n .
C o n t r o l s w i t h c o n s t i t u t i o n a . 1 v a r i a t i o n s o f h e i g h t w i t h i n t h e n
o r m a l r a n g e w e r e ( l i v e n o r n i t h i n e i n f u s i o n : t h e i n d u c e d r i s e o f GH c o r r e l a t e d w i t h a s i m u l t a n e o u s f a l l o f SM ( n = 2 3 , r = 0 . 7 1 1 ' p 4 0 . 0 0 1 ) a n d w i t h a f a l l o f Tf o c c u r r i n g 1 5 min. e a r l i e r ( n = 1 7 , r = 0 . 6 1 0 , p 4 0 . 0 1 ) .
I n 1 7 o b e s e c h i l d r e n SM was i n t h e n o r m a l r a n g e ( 1 . 0 8 f 0.11 U/ml), b a s a l Tf was h i g h e r ( 2 . 8 6 2 0 . 0 7 mg/ml, p ( 0 . 0 1 ) a n d GH a f t e r a r g i n i n e was l o w e r ( 4 . 4 6 ng/ml, p 4 0.001) t h a n i n c o n t r o l s . Tf a n d p e a k o f GH w e r e n e g a t i v e l y c o r r e l a t e d ( r = -0 . 6 0 8 , , p ( 0.01).
I n 1 4 h y p o p i t u i t a r y c h i l d r e r l , 6 mg o f hGH d l d n o t i n d u c e d v a r i a t i o n s o f Tf o v e r 24 h o u r s .
~.~.~s t e v e s * and J.R.Bierich, Department of Pediat., 44 University .
of Tubingen, 7400 Tubingen, F.R. Germany
Testosterone therapy i n boys with t a l l s t a t u r e .
Eleven t a l l boys were t r e a t e d with testosterone using a long acting testosterone preparation i n a mean dosage of 532 + 147 mg/m2/mo. Treatment was considered j u s t i f i e d i f predicted adult height was 195 cm o r more. 
5,3+1,5 cm. Hence it follows t h a t the reduction i s t h e greater
t h e e a r l i e r therapy i s s t a r t e d . Side e f f e c t s were i n general of minor degree. In 2 boys we had t o discontinue t h e treatment (severe akne and psychic disturbances).
D. GUPTA; R. ZAIS' a n d H . BUCHER'
D e p a r t m e n t o f D i a g n o s t i c E n d o c r i n o l o g y , U n i v e rs i t y C h i l d r e n ' s H o s p i t a l , 74 T u b i n g e n , FRG
The s e q u e n c e o f c h a n g e s i n t e s t i c u l a r r e s p o n s i v e n e s s t o HCG s t i m u l a t i o n a n d FSH p r i m i n g i n r a t s d u r i n g s e xu a l m a t u r a t i o n .
T e s t i c u l a r r e s p o n s i v e n e s s t o HCG a l o n e a n d w i t h FSH p r i m i n g i n i n t a c t r a t s o f 2 6 , 3 5 , 4 5 , 5 6 , 6 5 a n
d 76 d a y s o f a g e h a s b e e n s y s t e m a t i c a l l y i n v e s t i g a t e d . C i r c u l a t i n g l e v e l s o f t e s t o s t e r o n e a n d i t s two p o t e n t a n d r o g e n i c m et a b o l i t e s , 5a-dihydrotestosterone(DHT) a n d 3 a , 5 a -a n d r os t a n e d i o l ( A d i o 1 ) b e f o r e a n d a f t e r v a r i o u s d o s e s o f HCG ( 1 0 , 2 0 a n d 40 I U p e r 100 g b.w.) w e r e t a k e n a s t h e i n d e x o f t e s t i c u l a r r e s p o n s i v e n e s s a n d m e a s u r e d by r ad i o i m m u n o a s s a y . The e f f e c t s o f FSH p r i m i n g b e f o r e HCG a d m i n i s t r a t i o n w e r e a l s o s t u d i e d . T e s t i c u l a r r e s p o n s i v e -
n e s s t o HCG p r o g r e s s i v e l y i n c r e a s e d d u r i n g m a t u r a t i o n r e c o r d i n g maximum ( a v e r a g e 4600% o f t h e b a s a l v a l u e s ) a t a g e 35 a n d 45 d a y s . 20 I U o f HCG p e r 100 q b.w. was e n o u g h t o p r o v o k e maximum s t i m u l a t i o n w h i c h was i n d i st i n g u i s h a b l e f r o m t h a t d u e t o a l a r g e r d o s e . DHT a n d A d i o l w e r e m a x i m a l l y s t i m u l a t e d w i t h HCG a t 45 d a y s s h o w i n g n o f u r t h e r i n c r e m e n t w i t h m a t u r i t y . The magnit u d e o f t h e r e s p o n s e f o r DHT a n d A d i o l a p p e a r e d t o b e n e i t h e r r e l a t e d t o t h e d o s e o f HCG n o r t o t h e p r e t r e a tment w i t h FSH. T h i s s t u d y p o s t u l a t e s t h a t c h a n g i n g a nd r o g e n r e s p o n s e t o HCG may b e a m a j o r f a c t o r i n s e x u a l m a t u r a t i o n i n t h e m a l e r a t a n d i t i s i n f l u e n c e d by t h e FSH p r e t r e a t m e n t o n l y i n t h e m a t u r e a n i m a l s . Reproductive Capacity and Ultrastructure of Testis a f t e r LH-RH o r HCG Therapy f o r Cryptorchidism. 1 3 biopsies (A) from cryptorchid boys treated previously with LH-RH nasal spray were obtained during orchidopexy. For comparison 14 biopsies (B) from cryptorchid boys unsucessfully treated with HCC and 10 biopsies (C) without treatment were a l s o obtained during surgery and examined by l i g h t and electromicroscopy. A l l boys were of the same chronological age: A (2.9 k l.O), B (2.6 + 0.9) and C (3.0 2 1.5) years old. The normal descendent testicle has 1.4 L 0.3 spermatogonia p e r tubul us while cryptorchid boys had s i g n i f i c a n t l y lower spermatogonia tubul us (A -0.38 5 0.5; B -0.43 5 0.7; C -0.35 5 0.5). There was no s i g n i f i c a n t difference between the three groups concerning the number of spermatogonia. This observation shows t h a t nei Lter HCG-therapy (5000 El f o r 5 weeks) nor LH-RH-therapy (1.2 mg/day f o r 4 weeks) have a stimulatory e f f e c t on germ c e l l s . The res u l t s a l s o demonstrate t h a t there a r e no a n t i -f e r t i l i t y effects Tf was p o s i t i v e l y c o r r e l a t e d t o GV i n c o n t r o l s of LH-RH therapy. The most s t r i k i n g feature of Leydig c e l l s ( n = 1 5 , r = 0 . 7 0 4 , p ( 0 . 0 1 ) . t h e same c o r r e l a t i o n was a f t e r LW-RH treatment is the marked increase of c e l l s i z e and f o u n d when a d d i n g o b e s e a n d h y p o p i t u i t a r y s u b j e c t s t o smooth endoplasmic reticulum. These changes were i d e n t i c a l to t h e c o n t r o l g r o u p ( n = 4 1 , r =: 0 . 6 9 8 , p g 0 . 0 0 1 ) .
those observed a f t e r HCG treatment. Ultrastructurally, the
The w h o l e o f t h e s e d a t a s u g q e s t t h a t Tf i s i n v o l v e d
Leydig c e l l s show signs of stimulation and increased secretory i n g r o w t h r e g u l a t i o n a n d r e l a t . e d t o GH s e c r e t i o n b y a a c t i v i t y following LH-RH o r HCG treatment f o r cryptorchidism. f e e d b a c k mechanism.
